Risk Factors and Outcomes of Stem Cell Mobilization Failure in Multiple Myeloma Patients

INTRODUCTION: Autologous hematopoietic stem cell transplantation (ASCT) is a well-established treatment for patients with multiple myeloma (MM), and adequate stem cell collection must be assured before ASCT. However, prediction of poor mobilizers (PMs) is still difficult despite several risk factors...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Te-Lin, Tsai, Chun-Kuang, Liu, Chun-Yu, Yeh, Chiu-Mei, Lin, Fen-Lan, Hsiao, Liang-Tsai, Liu, Yao-Chung, Wang, Hao-Yuan, Ko, Po-Shen, Lin, Ting-An, Chen, Wen-Chun, Chen, Po-Min, Liu, Jin-Hwang, Gau, Jyh-Pyng, Liu, Chia-Jen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912005/
https://www.ncbi.nlm.nih.gov/pubmed/36818774
http://dx.doi.org/10.1159/000525565

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912005/
https://www.ncbi.nlm.nih.gov/pubmed/36818774
http://dx.doi.org/10.1159/000525565

Ejemplares similares